CN110396065A - A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- - Google Patents

A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- Download PDF

Info

Publication number
CN110396065A
CN110396065A CN201910556183.8A CN201910556183A CN110396065A CN 110396065 A CN110396065 A CN 110396065A CN 201910556183 A CN201910556183 A CN 201910556183A CN 110396065 A CN110396065 A CN 110396065A
Authority
CN
China
Prior art keywords
pyrimidine
chloro
bis
formyl chloride
synthetic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910556183.8A
Other languages
Chinese (zh)
Inventor
王小波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Prida Pharmaceutical Technology Co Ltd
Original Assignee
Nanjing Prida Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Prida Pharmaceutical Technology Co Ltd filed Critical Nanjing Prida Pharmaceutical Technology Co Ltd
Priority to CN201910556183.8A priority Critical patent/CN110396065A/en
Publication of CN110396065A publication Critical patent/CN110396065A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals

Abstract

The present invention provides the synthetic method of chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-, and synthesis step is as follows: taking urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride and mixes, is warming up to back flow reaction;After the completion of back flow reaction, cooling boils off excessive phosphorus oxychloride;Vacuum distillation obtains sterling.The present invention generates the chloro- 5- pyrimidine formyl chloride of 2,4- bis- using commercially available urea pyrimidine -5- formic acid as raw material, through superchlorination single step reaction;The starting material of reaction has a large amount of commercialization supplies, cheap and easy to get, and auxiliary material is recyclable to be applied, hence it is evident that while reducing cost, is avoided pollution of the noxious material to environment in production process, is improved the safety in operating process;Yield greatly improves, and effectively shortens the time, and easy to operate, postprocessing working procedures are simplified.

Description

A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis-
Technical field
The invention belongs to medicine intermediate fields, and in particular to the synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-.
Background technique
Pyrimidine ring is drug, one of most common heterocycle in natural products.Pyrimidine heterocyclic compounds are such as synthesizing The intermediate of drug has important application in field of medicaments, is widely used in anticancer drug, the research and development of anti-AIDS drug etc. Clinically.That there are synthetic routes is long for the synthetic method of the chloro- 5- pyrimidine formyl chloride of existing 2,4- bis-, yield is low, material toxicity is big And the shortcomings that environmental pollution.
Therefore, a kind of synthetic thread section, high income, and the synthetic method with high security are developed in view of the above problems It is those skilled in the art institute urgent need to solve the problem.
Summary of the invention
To solve the above problems, the invention discloses the synthetic methods of the chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-.
In order to achieve the above object, the invention provides the following technical scheme:
The synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-, synthesis step are as follows:
(1) urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride are taken and is mixed, back flow reaction is warming up to;
(2) after the completion of back flow reaction, cooling boils off excessive phosphorus oxychloride;
(3) vacuum distillation obtains sterling;
The above reaction equation are as follows:
Further, the weight ratio of urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride is 1:4-6 in step (1): 3-6。
Further, the mixed method of urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride is as follows: first that urea is phonetic Pyridine -5- formic acid is scattered in phosphorus oxychloride, is cooled to 5-10 DEG C, is added phosphorus pentachloride and is completed mixing.
Further, the temperature of back flow reaction is 100-120 DEG C in step (1), when reaction a length of 4-8h.
Further, phosphorus oxychloride is removed by distillation under vacuum in step (2).
Compared with prior art, the present invention 2 are generated through superchlorination single step reaction using commercially available urea pyrimidine -5- formic acid as raw material, The chloro- 5- pyrimidine formyl chloride of 4- bis-;The starting material of reaction has a large amount of commercialization supplies, cheap and easy to get, and auxiliary material is recyclable to be applied, bright It is aobvious while reduce cost, pollution of the noxious material to environment in production process is avoided, the safety in operating process is improved Property;Yield greatly improves, and effectively shortens the time, and easy to operate, postprocessing working procedures are simplified.
Specific embodiment
Technical solution provided by the invention is described in detail below with reference to specific embodiment, it should be understood that following specific Embodiment is only illustrative of the invention and is not intended to limit the scope of the invention.
Embodiment 1:
The present embodiment provides the synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-, synthesis step is as follows:
(1) it first disperses 125g urea pyrimidine -5- formic acid in 445ml phosphorus oxychloride, is cooled to 5-10 DEG C, adds 600g phosphorus pentachloride completes mixing, is warming up to 105 DEG C of progress back flow reactions, reacts duration 5h;
(2) after the completion of back flow reaction, cooling removes excessive phosphorus oxychloride by distillation under vacuum;
(3) vacuum distillation obtains sterling 168g, and purity is greater than 97%, yield 92%.
Embodiment 2:
The present embodiment provides the synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-, synthesis step is as follows:
(1) it first disperses 125g urea pyrimidine -5- formic acid in 300ml phosphorus oxychloride, is cooled to 5-10 DEG C, adds 400g phosphorus pentachloride completes mixing, is warming up to 100 DEG C of progress back flow reactions, reacts duration 6h;
(2) after the completion of back flow reaction, cooling removes excessive phosphorus oxychloride by distillation under vacuum;
(3) vacuum distillation obtains sterling 170g, and purity is greater than 97%, yield 93%.
Embodiment 3:
The present embodiment provides the synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- of one kind bis-, synthesis step is as follows:
(1) it first disperses 125g urea pyrimidine -5- formic acid in 400ml phosphorus oxychloride, is cooled to 5-10 DEG C, adds 500g phosphorus pentachloride completes mixing, is warming up to 100 DEG C of progress back flow reactions, reacts duration 7h;
(2) after the completion of back flow reaction, cooling removes excessive phosphorus oxychloride by distillation under vacuum;
(3) vacuum distillation obtains sterling 177g, and purity is greater than 97%, yield 96.8%.
Finally, it should be noted that property technical side the above examples are only used to illustrate the technical scheme of the present invention and are not limiting Case, those skilled in the art should understand that, modification or equivalent replacement of the technical solution of the present invention are made for those, and The objective and range for not departing from the technical program, are intended to be within the scope of the claims of the invention.

Claims (5)

1. one kind 2, the synthetic method of the chloro- 5- pyrimidine formyl chloride of 4- bis-, it is characterised in that: synthesis step is as follows:
(1) urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride are taken and is mixed, back flow reaction is warming up to;
(2) after the completion of back flow reaction, cooling boils off excessive phosphorus oxychloride;
(3) vacuum distillation obtains sterling;
The above reaction equation are as follows:
2. a kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- according to claim 1, it is characterised in that: described The weight ratio of urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride is 1:4-6:3-6 in step (1).
3. a kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- according to claim 2, it is characterised in that: described The mixed method of urea pyrimidine -5- formic acid, phosphorus oxychloride and phosphorus pentachloride is as follows: dispersing three for urea pyrimidine -5- formic acid first In chlorethoxyfos, it is cooled to 5-10 DEG C, phosphorus pentachloride is added and completes mixing.
4. a kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- according to claim 1, it is characterised in that: described The temperature of back flow reaction is 100-120 DEG C in step (1), when reaction a length of 4-8h.
5. a kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- according to claim 1, it is characterised in that: described Phosphorus oxychloride is removed by distillation under vacuum in step (2).
CN201910556183.8A 2019-06-25 2019-06-25 A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis- Pending CN110396065A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910556183.8A CN110396065A (en) 2019-06-25 2019-06-25 A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910556183.8A CN110396065A (en) 2019-06-25 2019-06-25 A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis-

Publications (1)

Publication Number Publication Date
CN110396065A true CN110396065A (en) 2019-11-01

Family

ID=68322617

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910556183.8A Pending CN110396065A (en) 2019-06-25 2019-06-25 A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis-

Country Status (1)

Country Link
CN (1) CN110396065A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1675225A (en) * 2002-08-21 2005-09-28 舍林股份公司 Macrocyclic pyrimidines, their production and use as pharmaceutical agents
CN101808996A (en) * 2007-09-28 2010-08-18 赛诺菲-安万特 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
CN104341388A (en) * 2013-10-16 2015-02-11 上海润诺生物科技有限公司 Aromatic amide derivative as well as preparation method and medicinal application thereof
CN105592850A (en) * 2013-08-06 2016-05-18 H·李·莫菲特癌症中心研究所公司 Inhibitors of ACK1/TNK2 tyrosine kinase

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1675225A (en) * 2002-08-21 2005-09-28 舍林股份公司 Macrocyclic pyrimidines, their production and use as pharmaceutical agents
CN101808996A (en) * 2007-09-28 2010-08-18 赛诺菲-安万特 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
CN105592850A (en) * 2013-08-06 2016-05-18 H·李·莫菲特癌症中心研究所公司 Inhibitors of ACK1/TNK2 tyrosine kinase
CN104341388A (en) * 2013-10-16 2015-02-11 上海润诺生物科技有限公司 Aromatic amide derivative as well as preparation method and medicinal application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
唐除痴等: "磷氯化物(PCl_3,PCl_5,POCl_3)作为氯化试剂在有机合成中应用的研究进展", 《化学研究》 *

Similar Documents

Publication Publication Date Title
CN104496917B (en) A kind of synthetic method of Favipiravir
CN108794370A (en) A kind of preparation method for drawing sieve to replace Buddhist nun's intermediate
CN104926798A (en) High purity preparation method of Afatinib intermediate
Liu et al. Synthesis of planar chiral isoquinolinone-fused ferrocenes through palladium-catalyzed CH functionalization reaction
CN102964391A (en) Chiral bisferrocene acylthiourea compound as well as synthesis method and application of compound
CN103254201A (en) Preparation method of asenapine
Bhat et al. First structurally characterized anion exchange product of noval cyclohexane containing substituted thio piperazinium chloride [C6H11S (CH2) 3C4H9N2C6H5Cl (L1Cl)]: Synthesis, crystal structure and supramolecularity of (L1NO3)
CN102911164A (en) Method for preparing lapatinib key intermediate
CN110396065A (en) A kind of synthetic method of the chloro- 5- pyrimidine formyl chloride of 2,4- bis-
CN102321086B (en) Synthesizing method of adenine
CN104496937A (en) Synthetic method of 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate
CN102924362B (en) Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride
CN104761505A (en) Preparation method for chloropyrimidine compound
CN104974057A (en) Preparation method and important intermediate of bromfenac sodium
CN106957270A (en) A kind of nitrouracil medicine supermolecule eutectic and preparation method thereof
CN102276537B (en) Preparation method of 2-cyan-5-amiopyrimidine
CN102344419A (en) Preparation method of broad-spectrum antifungal drug fluconazole
CN105218560A (en) The synthesis technique of 7-bromo-4-diuril phenol also [3,2-D] pyrimidine
CN101817781B (en) Synthetic method of 2-chloronicotinic acid
CN106146405B (en) Impurity of the drug intermediate and its preparation method and application
CN102796115A (en) Method for preparing temsirolimus
CN103467349B (en) Method utilizing methyl sodium sulfate offscum to synthesize S-methyl-iso-thiourea sulfate
CN103553986B (en) Method for preparing 3,4-diamino-benzenesulfonamide
CN110372605B (en) Synthesis method of 2-methylthio-4, 6-dichloro-5-nitropyrimidine
Huang et al. Nickel–heterocumulene complexes stabilized by trimethylphosphine: Synthesis, characterization and catalytic application in organozinc coupling with CS2

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191101

RJ01 Rejection of invention patent application after publication